Apple Analyst Sees $800 Ahead and 2 Stock Insights Making Rounds

Apple Inc. (NASDAQ:AAPL): Jefferies expects Apple Inc.’s growth to slow down and margin leverage to be negative in fiscal year 2014. The firm lowered their price target for shares from $900 to $800, but believe that Apple will post solid first and fourth quarter results. The firm keeps a Buy rating on their stock.

PriceSmart Inc. (NASDAQ:PSMT): Benchmark Co. thinks that  lower prices and macro economic conditions are hurting PriceSmart Inc.’s comps and operating margins. They lowered their price target for shares and keep a Hold rating on the stock.

Our 20-page proprietary analysis of Apple’s stock is ready. Click here and to get your Cheat Sheet report now!

Zogenix, Inc. (NASDAQ:ZGNX): Wells Fargo believes the Federal Drug Administration’s decision concerning Zogenix’s Zohydro ER could be different than the panel’s negative vote. They think that approval of the drug is a probable outcome and recommend buying shares of Zogenix, Inc. on any weakness from the negative panel vote.

Don’t Miss: Apple and Google Tag Team for This Power.